Mercier Johanna 4

Accession 0000882095-25-000037

CIK 0000882095other

Filed

Aug 17, 8:00 PM ET

Accepted

Aug 18, 8:56 PM ET

Size

27.2 KB

Accession

0000882095-25-000037

Form 4

Period: 2025-08-15

Chief Commercial Officer

Transactions

Sale
Common Stock
2025-08-15$118.97/sh−700$83,278→ 117,168 total
Sale
Common Stock
2025-08-15$118.51/sh−11,800$1,398,405→ 117,168 total
Exercise/Conversion
Common Stock
2025-08-15$66.64/sh+700$46,648→ 117,868 total
Sale
Common Stock
2025-08-15$118.97/sh−700$83,278→ 117,168 total
Sale
Common Stock
2025-08-15$118.97/sh−200$23,793→ 114,168 total
Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2025-08-15−700→ 110,610 total
Exercise: $66.64Exp: 2029-07-24→ Common Stock (700 underlying)
Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2025-08-15−11,800→ 98,810 total
Exercise: $66.64Exp: 2029-07-24→ Common Stock (11,800 underlying)
Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2025-08-15−700→ 98,110 total
Exercise: $66.64Exp: 2029-07-24→ Common Stock (700 underlying)
Sale
Common Stock
2025-08-15$118.50/sh−11,800$1,398,352→ 117,168 total
Exercise/Conversion
Common Stock
2025-08-15$66.64/sh+700$46,648→ 117,868 total
Exercise/Conversion
Common Stock
2025-08-15$66.64/sh+11,800$786,352→ 128,968 total
Sale
Common Stock
2025-08-15$118.51/sh−2,800$331,821→ 114,368 total
Exercise/Conversion
Common Stock
2025-08-15$66.64/sh+11,800$786,352→ 128,968 total
Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2025-08-15−11,800→ 111,310 total
Exercise: $66.64Exp: 2029-07-24→ Common Stock (11,800 underlying)

Footnotes (6)

[F1]The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
[F2]Sales prices for the transactions reported here range from $117.91 to $118.89. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
[F3]Sales prices for the transactions reported here range from $118.91 to $119.01. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or the shareowners upon request.
[F4]Sales prices for the transactions reported here range from $117.91 to $118.85. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
[F5]Sales prices for the transactions reported here range from $118.95 to $118.98. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
[F6]The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.

Documents

1 file

GILEAD SCIENCES, INC.

CIK 0000882095

Entity typeother